Physician

Gene H Kim, MD

According to 2025 Medicare claims, Gene Kim, MD (NPI: 1598923005) practices advanced heart failure and transplant cardiology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is UNIVERSITY OF CHICAGO (NPI: 1821048786; TIN: 36-2177139) and primary practice location at 60637-1447. Kim is affiliated with the UCMCNACO, LLC (ACO ID: A3531), participating under the MSSP model.

Kim's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,009 traditional Medicare patients, billed 1,841 HCPCS/CPT codes, and received $86,321 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 722 prescription claims across 157 beneficiaries totaling $2,420,685 in drug costs, led by Opsumit (Macitentan). DME data shows 202 claims. Open Payments data shows 20 records totaling $5,719. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $60,184 and ending at $86,321. Concurrently, Part D prescription costs have risen steadily, from $51,324 to $2,420,685. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $5,078 and ending at $13,146.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	133	552	$60,184
2016	145	724	$74,279
2017	163	675	$69,013
2018	185	800	$80,690
2019	476	929	$59,209
2020	830	1,471	$72,248
2021	1,354	2,418	$101,489
2022	932	1,541	$65,178
2023	744	1,268	$51,903
2024	1,009	1,841	$86,321

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	56	377	$51,324
2016	65	708	$67,505
2017	61	619	$51,174
2018	70	482	$56,639
2019	71	271	$39,044
2020	79	316	$83,266
2021	78	432	$108,903
2022	86	415	$291,990
2023	124	495	$1,724,006
2024	157	722	$2,420,685

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	118	$19,302
2016	N/R	107	$31,305
2017	N/R	138	$6,725
2018	N/R	78	$3,486
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	11	$166
2022	N/R	86	$6,837
2023	N/R	28	$226,357
2024	N/R	202	$307,655

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	40	40	$152
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	76	313	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	142	212	$92
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	91	132	$15
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	755	921	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Opsumit	Macitentan	87	2,610	$1,108,709
Adempas	Riociguat	39	1,170	$555,323
Camzyos	Mavacamten	21	615	$158,307
Ambrisentan	Ambrisentan	16	480	$65,586
Entresto	Sacubitril/Valsartan	44	1,920	$41,702

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7686	Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg	N	N/R	18	$291,646
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	57	$10,547
J2260	Injection, milrinone lactate, 5 mg	N	N/R	53	$3,922
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	56	$1,075
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	18	$466

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	19	$935	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$4,784	E.R. Squibb & Sons, L.L.C.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gene H. Kim, MD?

Tedicare shows public-source Medicare data for Gene H. Kim, MD (NPI 1598923005), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gene H. Kim, MD have ACO affiliation data?

Gene H. Kim, MD is shown with ACO affiliation data for UCMCNACO, LLC (MSSP, ACO ID A3531).

What billing organization is linked to Gene H. Kim, MD?

Gene H. Kim, MD is linked to UNIVERSITY OF CHICAGO (billing NPI 1821048786) in the available physician profile data.

Does Gene H. Kim, MD have Open Payments data?

Gene H. Kim, MD has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.